SENATE COMMITTEE ON HEALTH AND HUMAN SERVICES

March 28, 2001 Hearing Room B

1:00 PM Tapes 65 - 67

MEMBERS PRESENT: Sen. Bill Fisher, Chair

Sen. Margaret Carter, Vice-Chair

Sen. Gary George

Sen. Frank Shields

Sen. Ken Messerle

STAFF PRESENT: Rick Berkobien, Administrator

Andrew Morris, Committee Assistant

MEASURE/ISSUES HEARD: SB 405 Public Hearing and Work Session

SB 917 Public Hearing

These minutes are in compliance with Senate and House Rules. Only text enclosed in quotation marks reports a speaker’s exact words. For complete contents, please refer to the tapes.

TAPE/#	Speaker	Comments
TAPE 65, A
004	Chair Fisher	Calls meeting to order at 1:16 p.m. and opens a public hearing on SB 405.
SB 405 PUBLIC HEARING
008	Rick Berkobien	Administrator. Explains SB 405 to the committee.
024	Gary Schnabel	Executive Director, Board of Pharmacy. Testifies in support of SB 405 (EXHIBIT A). Explains the background of SB 405. Comments on fee increases and staffing levels.
066	Chair Fisher	Asks about the Legislative Fiscal Office impact statement.
075	Schnabel	Responds by explaining (EXHIBIT A).
093	Chair Fisher	Comments on delinquent renewal fees.
098	Schnabel	Discusses delinquent licensees. Refers to page three of (EXHIBIT A). States that drug manufactures are not interested in the fee increases. States that other parties are in favor of passage.
143	Chair Fisher	Reviews possible fee increases in the 2001-2003 budget cycle.
159	Schnabel	Comments on the fiscal statement.
174	Sen. Messerle	Asks about authority in fee increases.
178	Schnabel	Responds the Board of Pharmacy has the authority to raise fees.
190	Tom Holt	Oregon Pharmacy Association. Testifies in support of SB 405.
200	Sen. Messerle	Asks about the make-up of the pharmacy association.
207	Holt	Responds by explaining membership.
216	Chair Fisher	Comments on the budget of the Board of Pharmacy. Gives personal opinion on fee increases.
243	Schnabel	States that there has not been any opposition to the bill. Points out that it has been 10 years since any fee increases.
262	Holt	Comments on the discussion that took place during the drafting process.
280	Sen. Shields	Asks whom the bill would affect.
284	Holt	Responds by explaining who would be affected.
296	Sen. Shields	Comments on the budgeting process.
318	Chair Fisher	Discusses the budgeting process.
325	Sen. George	Asks for a list of people who would be affected.
332	Chair Fisher	Comments on people he has spoken with.
344	Schnabel	Explains how the proposed numbers were decided upon. Comments on policies that need to developed and computer updates that are needed.
370	Chair Fisher	Asks how many delinquent renewals there are annually.
379	Schnabel	Responds he is unsure, but estimates 100 to 300. Comments on licenses.
420	Chair Fisher	Asks about different types of licenses.
TAPE 66, A
000	Chair Fisher	Provides his personal opinion.
013	Schnabel	Explains the registration and licensing process. State the board tried to spread out the proposed fee increases.
030	Chair Fisher	Asks about the equity of payment between licensees.
032	Schnabel	Explains the equity situation. Comments on the current computer system the board uses.
052	Chair Fisher	Asks when the e-board is expecting the report on fee increases.
054	Schnabel	Responds the date is not set. Discusses investigation of complaints.
072	Chair Fisher	Closes the public hearing on SB 405 and opens a work session on SB 405.
077	Sen. Carter	MOTION: Moves SB 405 to the floor with a DO PASS recommendation.
		VOTE: 4-1 AYE: 4 - Carter, Messerle, Shields, Fisher NAY: 1 – George
181	Chair Fisher	The motion CARRIES. SEN. FISHER will lead discussion on the floor.
185	Chair Fisher	Closes the work session on SB 405 and opens a public hearing on SB 917.
SB 917 PUBLIC HEARING
190	Berkobien	Explains SB 917 to the committee.
225	Grover Simmons	Adult Care Providers Association. Testifies in support of SB 917. Comments on continuing education credit. Relates an experience where continuing education credits were disapproved.
290	Earlene Berry	President, Adult Care Providers of Oregon. Testifies in support of SB 917. Presents (EXHIBIT B). Comments on the role of providers. Explains reasons why business education courses are needed.
393	Chair Fisher	Asks how many hours of continuing education adult foster home providers usually have per year.
416	Berry	Responds that some years, up to 40 hours of continuing education is taken.
TAPE 65, B
004	Simmons	Comments on training that providers take.
008	Chair Fisher	Asks about approval for continuing education classes.
015	Berry	Responds permission has to be received from appropriate authorities before the classes are taken.
043	Sen. Carter	Asks if the business side and care side are considered a single or separate entity. Comments on training requirements. Provides personal opinion.
087	Chair Fisher	Comments on business practices. Provides opinion.
133	Sen. Shields	Asks about training ratios for care and business classes.
144	Berry	Responds by explaining the importance of business training.
169	Sen. Shields	Comments on continuing education credits.
188	Berry	Explains flexibility in training courses.
204	Chair Fisher	Discusses continuing education credits.
323	Berry	States that Adult Foster Homes are over regulated.
246	Cindy Hannum	Manager of Long Term Care Quality, Senior and Disabled Services Division, SDSD. Presents testimony in opposition to SB 917 (EXHIBIT C). Comments on the importance of continuing education.
305	Chair Fisher	States the bill is directed towards the license holders. Comments on reimbursement rates from SDSD.
330	Hannum	States concern about continuing education.
339	Chair Fisher	Provides opinion. States that appropriate credit needs to be given.
409	Sen. Messerle	Comments on the differences in training between business and care practices.
TAPE 66, B
000	Chair Fisher	Comments on SDSD’s role in supervising adult foster homes.
009	Hannum	States the importance of providing adequate care. Asks that SDSD would be given authority to review courses.
030	Chair Fisher	Comments on the needs for amendments.
040	Meredith Cote	Long-term Care Ombudsman. Testifies in opposition to SB 917. Comments on the importance of training. Proposes an idea for a possible amendment.
072	May Dasch	Oregon Chapters of the Alzheimer’s Association. Presents testimony in opposition to SB 917. Comments on the importance of continuing education. Discusses the importance of training on Alzheimer’s.
124	Sen. George	Asks who is in charge of continuing education curriculum.
130	Hannum	Responds SDSD.
147	Chair Fisher	Provides personal opinion.
174	Sen. George	Asks for Cote’s perception of Section 3.
176	Cote	Explains her viewpoint.
191	Chair Fisher	Asks about current continuing education requirements.
203	Hannum	Responds by explaining current practices.
233	Sen. George	Asks about the language of the bill.
242	Simmons	Responds by explaining the association’s position.
293	Sen. Shields	Asks if Oregon providers can change their practices.
300	Simmons	Responds that the association is working on informing people.
321	Sen. Carter	Asks about the licensing process.
330	Simmons	Responds by explaining current practices.
339	Berry	Comments on current industry standards.
404	Chair Fisher	Discusses the looming audit by the federal government.
438	Gabe Winslow	Legislative Aide to Sen. Charles Starr, SD 5. Testifies in support of SB 917.
TAPE 67, A
000	Winslow	Continues testimony.
037	Sen. Messerle	Asks about requirements to become licensed.
043	Chair Fisher	Responds by explaining situations that occur due to lack of licensing requirements. Comments on the role of counties.
095	Sen. Messerle	States concern about current licensing practices. Comments on business practices.
123	Chair Fisher	Provides personal opinion.
141	Chair Fisher	Closes the public hearing on SB 917 and adjourns the meeting at 3:22 p.m.

Submitted By, Reviewed By,

Andrew Morris, Rick Berkobien,

Committee Assistant Administrator

EXHIBIT SUMMARY

A – SB 405, Documentation in support of SB 405, Gary Schnabel, 5 pp.

B – SB 917, Written testimony, Earlene Berry, 3 pp.

C – SB 917, Written testimony, Cindy Hannum, 2 pp.

D – SB 917, Written testimony, Mary Dasch, 1 p.